Brady R J, Parsons R H, Coluccio L M
Biochim Biophys Acta. 1981 Sep 7;646(3):399-401. doi: 10.1016/0005-2736(81)90308-4.
Nocodazole is a synthetic antitumor drug that binds rapidly to tubulin. When this drug is applied to toad bladder prior to vasopressin stimulation it inhibits the vasopressin response. A maximum inhibition (68%) is reached with a dose level of 10 micrograms/ml applied one-half hour prior to vasopressin stimulation (20 mU/ml). This compares with an inhibition of 50% seen with a 3-h exposure of the tissue to colchicine (0.1 mM) prior to stimulation with vasopressin. Application of nocodazole (1 microgram/ml) 3 min after hormonal stimulation shows no inhibition of the response at one-half hour past stimulation. These data support the view that microtubules are involved in the vasopressin-induced increase in water permeability in toad bladder and also indicate that this involvement is limited to the period prior to or directly after stimulation.
诺考达唑是一种能迅速与微管蛋白结合的合成抗肿瘤药物。在血管加压素刺激蟾蜍膀胱之前应用这种药物,它会抑制血管加压素反应。在血管加压素刺激(20 mU/ml)前半小时应用剂量为10微克/毫升时,可达到最大抑制率(68%)。与之相比,在血管加压素刺激前将组织暴露于秋水仙碱(0.1 mM)3小时,抑制率为50%。在激素刺激3分钟后应用诺考达唑(1微克/毫升),在刺激后半小时未显示出对反应的抑制作用。这些数据支持微管参与血管加压素诱导蟾蜍膀胱水通透性增加的观点,也表明这种参与仅限于刺激前或刺激后直接的时间段。